E
BiomX Inc. PHGE
$4.98 -$0.06-1.19% AMEX
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2025 09/30/2025 06/30/2025 03/31/2025 12/31/2024
Net Income -36.20M -37.38M -18.57M -8.06M -17.73M
Total Depreciation and Amortization 2.92M 2.69M 1.77M 1.81M 1.80M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 6.91M 6.54M -13.45M -26.77M -18.06M
Change in Net Operating Assets -23.00K -149.00K 1.03M -1.31M -2.99M
Cash from Operations -26.39M -28.29M -29.21M -34.34M -36.98M
Capital Expenditure -2.00K -13.00K -21.00K -30.00K -30.00K
Sale of Property, Plant, and Equipment 110.00K 119.00K 128.00K 133.00K 82.00K
Cash Acquisitions -- 0.00 0.00 0.00 663.00K
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 108.00K 106.00K 107.00K 103.00K 715.00K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- 0.00 0.00 0.00 -10.75M
Issuance of Common Stock 13.31M 12.06M 12.00M 12.00M 25.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- 0.00 0.00 0.00 21.27M
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -118.00K -516.00K -516.00K -689.00K 27.83M
Cash from Financing 13.19M 11.54M 11.49M 11.31M 38.37M
Foreign Exchange rate Adjustments 73.00K 65.00K 86.00K 35.00K 1.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -13.02M -16.58M -17.53M -22.89M 2.11M